The BIO Protocol (BIO) allows on-chain scientific communities to fund, build, and co-own research and products in specific biomedical domains including lifespan, brain health, and rare disorders. BIO, founded by senior VitaDAO members, empowers worldwide communities of scientists, patients, and investors to take science into their own hands and bring solutions to life more effectively than traditional pharmaceutical companies.